vimarsana.com
Home
Live Updates
AlzeCure Pharma: AlzeCure Presents New Data at Alzheimer's C
AlzeCure Pharma: AlzeCure Presents New Data at Alzheimer's C
AlzeCure Pharma: AlzeCure Presents New Data at Alzheimer's Conference AD/PD on the Potential Disease-Modifying Effect of NeuroRestore ACD856
STOCKHOLM, SWEDEN / ACCESSWIRE / March 30, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
Related Keywords
Sweden ,
Stockholm ,
Swedish ,
Sanja Juric ,
Cristina Parrado Fern ,
Alzecure Pharma ,
Nather Madjid ,
Pontus Forsell ,
Alzecure Pharmaview ,
Gunnar Nordvall ,
Johan Sandin ,
Maria Backlund ,
,
Nasdaq First North Premier Growth Market ,
Nerve Growth Factor ,
Brain Derived Neurotrophic Factor ,
Alzecure ,
Dharma ,
Presents ,
Data ,
Lzheimer ,
Conference ,
Potential ,
Disease ,
Modifying ,
Effect ,
Neurorestore ,
Cd856 ,